Episode titled "From Medicine to Biotech Innovation" now availablePITTSBURGH, March 31, 2025 (GLOBE NEWSWIRE) -- Lipella ...

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Previously, Dr. Sellers directed cancer drug discovery and early cancer clinical development at the Novartis Institutes for ...

Panacea Biotec Limited has announced that Manjula Upadhyay, Independent Director of the Company, has completed her second and ...

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track –– Enrolling approximately one patient per week ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal ...

Intellia Therapeutics, Inc. NTLA is developing its lead CRISPR-based, in vivo genome-editing candidate, nexiguran ziclumeran (nex-z, formerly known as NTLA-2001) for the treatment of transthyretin ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

Researchers explore how natural compounds in traditional Chinese medicine can modulate cholesterol metabolism to combat ...